IPO GMP, subscription race: Reliance Jio Platforms vs Paras Healthcare - Grey market premium, QIB, NII, Retail details

Shore Bancshares delivers 84% return after Fair Value signal

Investing.com · News 54m ago

NovaBridge reports phase 1b data for gastric cancer drug

Investing.com · News 59m ago

Genmab reports phase 2 trial data for colorectal cancer drug

Investing.com · News 59m ago

InvestingPro Fair Value predicted 50% decline in Kardigan stock

Investing.com · News 1h ago

Hyperscale Data CEO William Horne buys $16,800 in common stock

Investing.com · News 1h ago

Is Spotify Technology SA a Buy After Its Latest Earnings Report?

NASDAQ · Markets 1h ago

Where Will Broadcom Stock Be in 5 Years?

NASDAQ · Markets 1h ago

We're Witnessing the Stock Market Do Something for Only the 3rd Time in the Last 100 Years, and History Is Crystal Clear on What's Next for Stocks

NASDAQ · Markets 1h ago

The Next Palantir? Why This Under-the-Radar Software Stock Could Be the Biggest Surprise of 2027

NASDAQ · Markets 1h ago

UBS may cut 12,000 Swiss jobs if capital rules tighten - report

Investing.com · News 1h ago